vt3989
vivace therapeutics
['concept data', 'vt3989']
researchers report clinical proof-of-concept data for vivace therapeutics' vt3989, a first for a cancer drug targeting the hippo pathway, in oral presentation at aacr #business
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.